|
|
FOR IMMEDIATE RELEASE September 29, 2004. Developer of the Personal Cell Analysis (PCA) system and reagents - Guava Technologies, Inc. and GE Healthcare have expanded the geographic scope of their previously announced exclusive three-year distribution agreement in Japan, to include South Korea, Mexico and certain countries in Latin America and the Caribbean. Guava Technologies & GE Healthcare Expand Cellular Analysis Solutions Distribution Agreement .. Developer of the Personal Cell Analysis (PCA) system and reagents - Guava Technologies, Inc. and GE Healthcare have expanded the geographic scope of their previously announced exclusive three-year distribution agreement in Japan, to include South Korea, Mexico and certain countries in Latin America and the Caribbean. "The Guava PCA systems are complementary to GE Healthcare's cellular analysis reagents and the IN Cell Analyzer. Together they provide a comprehensive cellular analysis offering, supported by GE Healthcare's extensive distribution, marketing, sales and support franchise. Compatibility of reagents from both companies across the IN Cell Analyzer and PCA Platforms will simplify and improve cellular analysis applications and extend a more complete systems offering to customers," said John Sutton, vice president product management, cellular analysis, GE Healthcare. The Guava Technologies' products now available from GE Healthcare include the Guava PCA and PCA-96 Platforms with software modules and reagent kits including Guava ViaCount®, Nexin, Express, MultiCaspase, TUNEL, Cell Cycle, CellToxicity, CellPaint and the Express AFP software Modules. About Guava Technologies Guava Technologies is a biotechnology company that develops, manufactures and markets unique integrated cellular analysis systems for the life science researcher's benchtop. The company is revolutionising the way that cell culture monitoring and cell screening assays are performed, by providing compact micro-volume scale systems that make common assays in cell-based analysis accessible at the benchtop. Guava's products have broad applications to life sciences research, drug discovery and biopharmaceutical production today, but also offer potential for use in clinical testing and blood processing, as well as other areas where single cell analysis is important. More information about Guava Technologies is available at www.guavatechnologies.com About GE Healthcare GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing is dedicated to detecting disease earlier and tailoring treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, Alzheimer's and cardiovascular diseases. GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit www.gehealthcare.com
CONTACTS:
|
Home | News | CombiChem | CombiChem Links | HTS | Lab Automation
Sales | Email Us | Repairs | Disclaimer | © 1999-2004